Caris Life Sciences
About Caris Life Sciences
Caris Life Sciences is a leading AI TechBio company and pioneer in precision medicine, dedicated to revolutionizing healthcare by providing physicians and patients with comprehensive, data-driven insights into disease. The company was founded on the belief that combining vast molecular information with robust data analytics can unlock the full potential of personalized medicine. Caris achieves this through advanced molecular profiling, utilizing Whole Exome and Whole Transcriptome Sequencing (WES/WTS) of both tissue and blood samples, alongside immunohistochemistry (IHC) of key proteins. [1, 2, 22, 26, 27]
Through the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has built one of the largest clinico-genomic databases globally. This extensive database and cognitive computing capability enable the analysis and unraveling of the molecular complexity of diseases, primarily focusing on cancer. The insights generated help clinicians navigate among potential therapies, identify novel treatment options, determine drugs unlikely to provide benefit (thereby avoiding unnecessary toxicities and costs), and match patients to appropriate clinical trials. [1, 2, 22, 26, 27]
While Caris has a primary focus on oncology, developing market-leading precision medicine tools that have aided over half a million cancer patients worldwide, its precision medicine approach extends to other disease areas. These include cardiology, neurology, and various metabolic conditions, demonstrating a broader vision for improving the human condition through molecular science and AI-driven solutions. [1, 2, 8, 25]
Focus Areas
Business Intelligence
| Key Investors | Braidwell, Perceptive Advisors, Woodline, Ghisallo Capital Management, Millennium Management, First Light Asset Management, Sixth Street, T. Rowe Price, Silver Lake, Fidelity Investments, Coatue, Neuberger Berman, Highland Capital Management, Columbia Threadneedle Investments, CPP Investments, Orbimed |
| Partnerships | Meaningful Insights Biotech Analytics (MiBA), Genentech, Ontada, Merck KGaA, Moderna, Incyte, Flatiron Health, UCSF Helen Diller Family Comprehensive Cancer Center |
| Acquisitions | Pharmatech, Inc. |
| Technology | AI and machine learning algorithms, proprietary AI analytics engine DEAN, comprehensive molecular profiling (Whole Exome Sequencing, Whole Transcriptome Sequencing, Whole Genome Sequencing, protein analysis, immunohistochemistry), large-scale clinico-genomic database, Caris Nanoverse™, Caris CODEai™ |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Caris Life Sciences offers unparalleled molecular insights to personalize cancer treatment. Utilize their comprehensive molecular profiling (tissue or liquid biopsy) to navigate therapy options, identify potentially beneficial treatments, avoid unnecessary toxicities and costs from ineffective drugs, and efficiently match patients to relevant clinical trials. Leverage their AI-driven predictive algorithms for deeper understanding of tumor biology and therapy response. Take advantage of their expert scientific and clinical support, including report interpretation and Medical Science Liaison assistance, to integrate precision medicine best practices into your patient care. Their EHR integrations can streamline your workflow for seamless access to critical patient data.
Caris Life Sciences offers EHR integrations to facilitate seamless access to molecular profiling results and patient data, enabling a more efficient and integrated precision medicine workflow within existing healthcare systems.
What the Web Says
Caris Life Sciences is a precision oncology company that utilizes advanced molecular profiling and AI to develop cancer diagnostics and guide treatment. The company's products, such as MI Cancer Seeku00ae and Caris Assureu2122, are designed to provide comprehensive molecular blueprints of tumors and track cancer with liquid biopsies. While patient testimonials highlight the life-changing impact of Caris's technology, employee reviews often point to significant issues within the company culture and management.
Overall: MixedStrengths
- Meaningful work in cancer research and precision oncology.
- Good pay for some positions.
- Extensive training for assays.
- Opportunities for molecular assay experience and potential for upward movement.
- Innovative use of AI for cancer detection and therapy selection.
- Strong employee retention with staff staying an average of 4.5 years.
Limitations
- Toxic company culture and favoritism.
- Poor and micromanaging leadership/management.
- Bad work-life balance and mandatory overtime.
- Disorganization, confusion, and constant shifts in processes without clear communication.
- Terrible benefits despite good pay in some instances.
- Repetitive job tasks with little room for advancement in some roles.
Based on reviews from: Indeed.com, Reddit, Zippia, PR Newswire, YouTube, TIKR.com
Last updated: 2026-07-24
Videos
News, demos, and interviews about Caris Life Sciences.
Videos load interactively. If none appear, search YouTube for Caris Life Sciences →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Caris Life Sciences.
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]